Related Experiment Video
Updated: Jan 18, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Morphine and treatment of cancer -related pain-risk or benefit?
Jie Wang1, Pengfei Guo1, Yanfei Bian1
1Anesthesiology Department, The Third Hospital of Baogang Group, Baotou, P. R. China.
Abstract:
Morphine has been widely used to treat physical non-cancer pain as well as cancer-related pain. However, a growing body of evidence has emerged indicating that morphine in addition to alleviating pain initiates and suppresses immune functions in different types of cancer. At present the actions of morphine on tumor growth are contradictory with both inhibition and stimulation reported. Thus, the effects of morphine use needs to be identified with respect to the immune system in consideration of the therapeutic course to follow. It is known that cancer cells express various types of opioid receptors and morphine interaction with these receptors needs to be elucidated in cancer treatment. The expression and distribution of different opioid receptors for morphine binding may provide a basis for varying effects attributed to morphine actions on cancer cell promotion and suppression. Evidence indicates that knowledge regarding distribution of opioid receptors may be considered as a therapeutic tool to determine the use of morphine as a painkiller to treat cancer-related pain.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Opioid Receptors: Overview
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

